FPSUF (Capha Pharmaceuticals) Interest Coverage: No Debt (1) (As of Jun. 2025)


What is Capha Pharmaceuticals Interest Coverage?

Capha Pharmaceuticals FPSUF Interest Coverage is No Debt (1) as of Jun. 2025.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Capha Pharmaceuticals's Operating Income for the three months ended in Jun. 2025 was $-0.01 Mil. Capha Pharmaceuticals's Interest Expense for the three months ended in Jun. 2025 was $0.00 Mil. Capha Pharmaceuticals has no debt. The higher the ratio, the stronger the company's financial strength is.

(1) Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Capha Pharmaceuticals's Interest Coverage or its related term are showing as below:


FPSUF's Interest Coverage is not ranked *
in the Drug Manufacturers industry.
Industry Median: 12.75
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Capha Pharmaceuticals  (OTCPK:FPSUF) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Capha Pharmaceuticals Interest Coverage Related Terms

Capha Pharmaceuticals Interest Coverage Historical Data

* Premium members only.

The historical data trend for Capha Pharmaceuticals's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Capha Pharmaceuticals Interest Coverage Chart

Capha Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Coverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only No Debt No Debt No Debt No Debt No Debt

Capha Pharmaceuticals Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only No Debt No Debt No Debt No Debt No Debt

FPSUF vs GRYN, TAUG, ZTS: Interest Coverage Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Capha Pharmaceuticals's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Capha Pharmaceuticals Interest Coverage vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Capha Pharmaceuticals's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Capha Pharmaceuticals's Interest Coverage falls into.


Capha Pharmaceuticals Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Capha Pharmaceuticals's Interest Coverage for the fiscal year that ended in Dec. 2024 is calculated as

Here, for the fiscal year that ended in Dec. 2024, Capha Pharmaceuticals's Interest Expense was $0.00 Mil. Its Operating Income was $-0.05 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.00 Mil.

Capha Pharmaceuticals had no debt (1).

Capha Pharmaceuticals's Interest Coverage for the quarter that ended in Jun. 2025 is calculated as

Here, for the three months ended in Jun. 2025, Capha Pharmaceuticals's Interest Expense was $0.00 Mil. Its Operating Income was $-0.01 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.00 Mil.

Capha Pharmaceuticals had no debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Frequently Asked Questions Learn more about Interest Coverage →
What does a Interest Coverage of No Debt <sup>(1)</sup> mean?
Capha Pharmaceuticals (FPSUF) has a Interest Coverage of No Debt (1) as of Jun. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Capha Pharmaceuticals and its competitors.
Is Capha Pharmaceuticals' Interest Coverage too high?
Capha Pharmaceuticals' current Interest Coverage is No Debt (1).
How does Capha Pharmaceuticals' Interest Coverage compare to GRYN and TAUG?
Capha Pharmaceuticals' Interest Coverage of No Debt (1) can be compared against companies in the Drug Manufacturers industry. The industry median Interest Coverage is 12.75. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.75, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Capha Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Capha Pharmaceuticals's current Interest Coverage is No Debt (1). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Capha Pharmaceuticals stock overvalued right now?
Capha Pharmaceuticals (FPSUF) has a current Interest Coverage of No Debt (1). The current Interest Coverage is No Debt (1). Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Capha Pharmaceuticals (FPSUF), the current Interest Coverage is No Debt (1) as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Capha Pharmaceuticals Business Description

Address 4205 Gellatly Road, Suite 324, West Kelowna, BC, CAN, V4T 2K2
Capha Pharmaceuticals Inc is a Canada-based company principally operating in the pharmaceutical industry. The company produces and distributes products in Canada and the United States of America.